test

A Single-arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates

Conditions

Hypercalcemia

What is the purpose of this trial?


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Amgen, Inc
Dates:
February 2010
Last Updated:
Study HIC#:
0908005536